Navigation Links
Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Date:8/19/2007

unding on favorable terms, continued operating losses and the inability to continue operations as a result, and a variety of other risks set forth from time to time in Vion's filings with the Securities and Exchange Commission, including but not limited to the risks attendant to the forward-looking statements included under Item 1A, "Risk Factors" in Vion's Annual Report on Form 10-K for the year ended December 31, 2006 and the Company's Form 10-Q for the quarter ended June 30, 2007. In particular, there can be no assurance as to the results of any of the Company's clinical trials, that any of these trials will continue to full accrual, or that any of these trials will not be discontinued, modified, delayed or ceased altogether. Except in special circumstances in which a duty to update arises under law when prior disclosure becomes materially misleading in light of subsequent events, Vion does not intend to update any of these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

COMPANY CONTACT: Vion Pharmaceuticals, Inc.

Alan Kessman, Chief Executive Officer

Howard B. Johnson, President & CFO

(203) 498-4210


'/>"/>
SOURCE Vion Pharmaceuticals, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015  (MUSE Booth ... Electronic Health Record (EHR) is invaluable in any ... EHRs are now a requirement and mainstream in ... continuously into the EHR is gaining traction in ... William Holmes, RN, Site Project Manager & Clinical ...
(Date:5/21/2015)... , 21. Mai 2015 /PRNewswire/ ... DPRX ), ein Unternehmen für Arzneimittel ... die Entwicklung und Vermarktung von Locilex® ... kündigte heute eine wissenschaftliche Posterpräsentation an, ... des Unternehmens vorstellt, OneStep-1 und OneStep-2, ...
(Date:5/21/2015)... May 21, 2015  Heidrick & Struggles (Nasdaq: ... , leadership consulting and culture shaping ... among global practices announcing the addition of Tim ... office. Dietlin has extensive life ... and across R&D, Medical and Commercial functions to increase ...
Breaking Medicine Technology:Hospital Streamlines ICU Efficiency with Timely Data Integration 2Hospital Streamlines ICU Efficiency with Timely Data Integration 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 4Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 5Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 6Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 7Heidrick Increases Healthcare and Life Sciences Expertise 2
... REDWOOD CITY, Calif., Oct. 19 Ingenuity® Systems, ... science researchers, and TransMed Systems, a translational medicine ... between IPA® software and XB Bio-Integration Suite (XB-BIS). ... data that is managed and statistically analyzed by ...
... Results From the Intermezzo® Highway Driving Study -- POINT RICHMOND, Calif., Oct. 19 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // ...
Cached Medicine Technology:Ingenuity Systems and TransMed Systems Integrate Software to Support Personalized Medicine Research 2Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 2Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 3Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 4Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 5Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 6Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 7Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 8Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 9Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 10Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 11Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 12Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 13Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 14
(Date:5/23/2015)... On May 16, the team at Farrell’s ... 5k mud obstacle run that raised funds for multiple sclerosis. ... and the reason we participated was to support people living ... Farrell’s eXtreme Bodyshaping. “One-hundred percent of the funds raised go ... was not only attended by eXtreme Bodyshaping staff, but members ...
(Date:5/23/2015)... Javon Bea Mercy Health System CEO ... Rehabilitation Center, 557 N. Washington St., Janesville, will host ... 5:30-6:30 pm. , The 8-week clinic is lead by ... BSN, who will offer training that encompasses a warm-up, ... and show selection and weekly training plans. , The ...
(Date:5/22/2015)... The world is at a "hinge ... to create new opportunities for leadership in health ... WesternU's 34th annual Commencement Exercises said Wednesday, May ... former San Francisco mayor and likely 2018 gubernatorial ... ceremony for WesternU's colleges of Allied Health Professions ...
(Date:5/22/2015)... Utah (PRWEB) May 22, 2015 Mountain Point ... host a ribbon cutting ceremony on Friday, May 29, 2015 ... p.m. to 6 p.m. The new medical center, set to ... North Triumph Boulevard, Lehi, UT 84043. , “The opening ... our team and the Utah County community,” said Kent Loosle, ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Following yesterday’s ... sale agreement with US-based health brand Nature’s Way, Marc ... brand. Retention of Ascenta Skin is an integral part ... excited about this opportunity to further develop Ascenta Skin ... , Ascenta Skin is a breakthrough, anti-aging skincare supplement ...
Breaking Medicine News(10 mins):Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2Health News:Newsom to WesternU Grads: The Future is Inside You 2Health News:Newsom to WesternU Grads: The Future is Inside You 3Health News:Mountain Point Medical Center, a Campus of Jordan Valley Medical Center, Hosts Ribbon Cutting Ceremony and Community Celebration on Friday, May 29, 2015 2Health News:Ascenta Skin President Announces Plans to Grow Brand 2
... India is on high alert to tackle any Bird Flu ... Institute of Medical Sciences (AIIMS)' and another 20// bedded ward ... to treat any of the patients with avian influenza or ... has been the instruction to food restaurant in the city ...
... a world-class cancer hospital and research center, Tata Medical Centre ... cost of Rs. 1.2 billion. ,The cancer hospital known ... a 10-acre plot, West Bengal Chief Minister Buddhadeb Bhattacharjee and ... stone for the project scheduled to be completed by December ...
... to the news that that bird flu was found in chickens in ... ,The change has affected Leong Hup, Farm's Best and CAB// Cakaran ... to RM2.66 while Farm's Best shares and warrants lost 55 sen and ... sen to RM1.08. ,Among other poultry stocks, Lay ...
... can now be predicted by using a simple, non-invasive ... // The device measures the arterial stiffness and ... the heart. The results of the study can be ... ,More than 40% of Americans are at ...
... Mc Donald’s fried in another controversy which pertains to its ... filed in United States over its use of wheat and ... of contention is that these constituents might trigger allergy in ... of trans fat in a large serving of fries is ...
... blame all those people who had been telling you to ... for bone strength but is not the only one.,It works ... per a recent study which is part of Woman's Health ... supplements may not be effective in preventing osteoporosis in postmenopausal ...
Cached Medicine News:Health News:Heart Disease Risk Can Now Be Predicted By A Painless, Non-Invasive Test 2Health News:Calcium in isolation no good for maintaining bone integrity 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: